{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:45Z","timestamp":1790787225328,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12975-019-00699-7","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T20:03:42Z","timestamp":1552939422000},"page":"4-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Vascular Arginase Is a Relevant Target to Improve Cerebrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Evidence from the Model of Adjuvant-Induced Arthritis"],"prefix":"10.1007","volume":"11","author":[{"given":"Romain","family":"Bordy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Quiri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perle","family":"Totoson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Demougeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"699_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690\u20137. \nhttps:\/\/doi.org\/10.1002\/art.24092\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR2","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036. \nhttps:\/\/doi.org\/10.1136\/bmj.k1036\n\n.","journal-title":"BMJ"},{"key":"699_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jbspin.2014.01.014","volume":"81","author":"C Prati","year":"2014","unstructured":"Prati C, Demougeot C, Guillot X, Godfrin-Valnet M, Wendling D. Endothelial dysfunction in joint disease. Joint Bone Spine. 2014;81:386\u201391. \nhttps:\/\/doi.org\/10.1016\/j.jbspin.2014.01.014\n\n.","journal-title":"Joint Bone Spine"},{"key":"699_CR4","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/ijms19071890","volume":"19","author":"A Arida","year":"2018","unstructured":"Arida A, Protogerou AD, Kitas GD, Sfikakis PP. Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases. Int J Mol Sci. 2018;19:1890. \nhttps:\/\/doi.org\/10.3390\/ijms19071890\n\n.","journal-title":"Int J Mol Sci"},{"key":"699_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41584-018-0022-8","volume":"14","author":"R Bordy","year":"2018","unstructured":"Bordy R, Totoson P, Prati C, Marie C, Wendling D, Demougeot C. Microvascular endothelial dysfunction in rheumatoid arthritis. Nat Rev Rheumatol. 2018;14:404\u201320. \nhttps:\/\/doi.org\/10.1038\/s41584-018-0022-8\n\n.","journal-title":"Nat Rev Rheumatol"},{"key":"699_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","volume":"47","author":"SJ Wiseman","year":"2016","unstructured":"Wiseman SJ, Ralston SH, Wardlaw JM. Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis. Stroke. 2016;47:943\u201350. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.115.012052\n\n.","journal-title":"Stroke"},{"key":"699_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.autrev.2017.10.011","volume":"16","author":"F Atzeni","year":"2017","unstructured":"Atzeni F, Pipitone N, Iaccarino L, Masala IF, Weiss R, Alciati A, et al. Rheumatic diseases and autoimmune vascular dementia. Autoimmun Rev. 2017;16:1265\u20139. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2017.10.011\n\n.","journal-title":"Autoimmun Rev"},{"key":"699_CR8","first-page":"1896","volume":"31","author":"F Wolfe","year":"2004","unstructured":"Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol. 2004;31:1896\u2013902.","journal-title":"J Rheumatol"},{"key":"699_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/acr.23243","volume":"70","author":"T Meade","year":"2018","unstructured":"Meade T, Manolios N, Cumming SR, Conaghan PG, Katz P. Cognitive impairment in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2018;70:39\u201352. \nhttps:\/\/doi.org\/10.1002\/acr.23243\n\n.","journal-title":"Arthritis Care Res"},{"key":"699_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/acr.21683","volume":"64","author":"SY Shin","year":"2012","unstructured":"Shin SY, Katz P, Wallhagen M, Julian L. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res. 2012;64:1144\u201350. \nhttps:\/\/doi.org\/10.1002\/acr.21683\n\n.","journal-title":"Arthritis Care Res"},{"key":"699_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCRESAHA.116.308427","volume":"120","author":"X Hu","year":"2017","unstructured":"Hu X, De Silva TM, Chen J, Faraci FM. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ Res. 2017;120:449\u201371. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308427\n\n.","journal-title":"Circ Res"},{"key":"699_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00004647-200002000-00011","volume":"20","author":"A Elhusseiny","year":"2000","unstructured":"Elhusseiny A, Hamel E. Muscarinic-but not nicotinic-acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype. J Cereb Blood Flow Metab. 2000;20:298\u2013305. \nhttps:\/\/doi.org\/10.1097\/00004647-200002000-00011\n\n.","journal-title":"J Cereb Blood Flow Metab"},{"key":"699_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/01.RES.0000146279.11923.14","volume":"95","author":"GL Baumbach","year":"2004","unstructured":"Baumbach GL, Sigmund CD, Faraci FM. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circ Res. 2004;95:822\u20139. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000146279.11923.14\n\n.","journal-title":"Circ Res"},{"key":"699_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1152\/physrev.1998.78.1.53","volume":"78","author":"FM Faraci","year":"1998","unstructured":"Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53\u201397. \nhttps:\/\/doi.org\/10.1152\/physrev.1998.78.1.53\n\n.","journal-title":"Physiol Rev"},{"key":"699_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pr.108.000547","volume":"61","author":"N Toda","year":"2009","unstructured":"Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61:62\u201397. \nhttps:\/\/doi.org\/10.1124\/pr.108.000547\n\n.","journal-title":"Pharmacol Rev"},{"key":"699_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB. Arginase: a multifaceted enzyme important in health and disease. Physiol Rev. 2018;98:641\u201365. \nhttps:\/\/doi.org\/10.1152\/physrev.00037.2016\n\n.","journal-title":"Physiol Rev"},{"key":"699_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar4450","volume":"16","author":"P Totoson","year":"2014","unstructured":"Totoson P, Maguin-Gat\u00e9 K, Prati C, Wendling D, Demougeot C. Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Res Ther. 2014;16:202. \nhttps:\/\/doi.org\/10.1186\/ar4450\n\n.","journal-title":"Arthritis Res Ther"},{"key":"699_CR18","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/art.30391","volume":"63","author":"C Prati","year":"2011","unstructured":"Prati C, Berthelot A, Wendling D, Demougeot C. Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway. Arthritis Rheum. 2011;63:2309\u201317. \nhttps:\/\/doi.org\/10.1002\/art.30391\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR19","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/ar3860","volume":"14","author":"C Prati","year":"2012","unstructured":"Prati C, Berthelot A, Kantelip B, Wendling D, Demougeot C. Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis. Arthritis Res Ther. 2012;14:R130. \nhttps:\/\/doi.org\/10.1186\/ar3860\n\n.","journal-title":"Arthritis Res Ther"},{"key":"699_CR20","first-page":"56","volume":"44","author":"SJ Oliver","year":"1996","unstructured":"Oliver SJ, Brahn E. Combination therapy in rheumatoid arthritis: the animal model perspective. J Rheumatol Suppl. 1996;44:56\u201360.","journal-title":"J Rheumatol Suppl"},{"key":"699_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454\u201360. \nhttps:\/\/doi.org\/10.1038\/nature02119\n\n.","journal-title":"Nature"},{"key":"699_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/art.39065","volume":"67","author":"P Totoson","year":"2015","unstructured":"Totoson P, Maguin-Gat\u00e9 K, Nappey M, Prati C, Wendling D, Demougeot C. Microvascular abnormalities in adjuvant-induced arthritis: relationship to macrovascular endothelial function and markers of endothelial activation. Arthritis Rheum. 2015;67:1203\u201313. \nhttps:\/\/doi.org\/10.1002\/art.39065\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/art.1780221208","volume":"22","author":"NR Ackerman","year":"1979","unstructured":"Ackerman NR, Rooks WH, Shott L, Genant H, Maloney P, West E. Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum. 1979;22:1365\u201374. \nhttps:\/\/doi.org\/10.1002\/art.1780221208\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2017.09.033","volume":"266","author":"F Verhoeven","year":"2017","unstructured":"Verhoeven F, Totoson P, Marie C, Prigent-Tessier A, Wendling D, Tournier-Nappey M, et al. Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: a study in adjuvant-induced arthritis. Atherosclerosis. 2017;266:136\u201344. \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.033\n\n.","journal-title":"Atherosclerosis"},{"key":"699_CR25","doi-asserted-by":"publisher","first-page":"H1846","DOI":"10.1152\/ajpheart.00691.2015","volume":"309","author":"SD Brooks","year":"2015","unstructured":"Brooks SD, DeVallance E, d\u2019Audiffret AC, et al. Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol. 2015;309:H1846\u201359. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00691.2015\n\n.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"699_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/978-1-4939-3816-2_33","volume":"1462","author":"MA Anwar","year":"2016","unstructured":"Anwar MA, Eid AH. Determination of vascular reactivity of middle cerebral arteries from stroke and spinal cord injury animal models using pressure myography. Methods Mol Biol Clifton NJ. 2016;1462:611\u201324. \nhttps:\/\/doi.org\/10.1007\/978-1-4939-3816-2_33\n\n.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"699_CR27","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.21891","volume":"54","author":"Y Haruna","year":"2006","unstructured":"Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, et al. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase. Arthritis Rheum. 2006;54:1847\u201355. \nhttps:\/\/doi.org\/10.1002\/art.21891\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR28","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/art.22632","volume":"56","author":"Y Haruna","year":"2007","unstructured":"Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum. 2007;56:1827\u201335. \nhttps:\/\/doi.org\/10.1002\/art.22632\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1006\/niox.1999.0255","volume":"3","author":"JP Tenu","year":"1999","unstructured":"Tenu JP, Lepoivre M, Moali C, Brollo M, Mansuy D, Boucher JL. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide Biol Chem. 1999;3:427\u201338. \nhttps:\/\/doi.org\/10.1006\/niox.1999.0255\n\n.","journal-title":"Nitric Oxide Biol Chem"},{"key":"699_CR30","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1124\/jpet.106.103747","volume":"318","author":"G Topal","year":"2006","unstructured":"Topal G, Topal J-LG, Brunet A, et al. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther. 2006;318:1368\u201374. \nhttps:\/\/doi.org\/10.1124\/jpet.106.103747\n\n.","journal-title":"J Pharmacol Exp Ther"},{"key":"699_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/HJH.0b013e3282fcc357","volume":"26","author":"T Bagnost","year":"2008","unstructured":"Bagnost T, Berthelot A, Bouhaddi M, Laurant P, Andr\u00e9 C, Guillaume Y, et al. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. J Hypertens. 2008;26:1110\u20138. \nhttps:\/\/doi.org\/10.1097\/HJH.0b013e3282fcc357\n\n.","journal-title":"J Hypertens"},{"key":"699_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13075-017-1422-x","volume":"19","author":"C Ol\u00e1h","year":"2017","unstructured":"Ol\u00e1h C, Kardos Z, Sepsi M, Sas A, Kosty\u00e1l L, Bhattoa HP, et al. Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis. Arthritis Res Ther. 2017;19:213. \nhttps:\/\/doi.org\/10.1186\/s13075-017-1422-x\n\n.","journal-title":"Arthritis Res Ther"},{"key":"699_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-018-1616-x","volume":"20","author":"UM Chandrasekharan","year":"2018","unstructured":"Chandrasekharan UM, Wang Z, Wu Y, Wilson Tang WH, Hazen SL, Wang S, et al. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis. Arthritis Res Ther. 2018;20:123. \nhttps:\/\/doi.org\/10.1186\/s13075-018-1616-x\n\n.","journal-title":"Arthritis Res Ther"},{"key":"699_CR34","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.2174\/13816128113196660746","volume":"20","author":"S Luo","year":"2014","unstructured":"Luo S, Lei H, Qin H, Xia Y. Molecular mechanisms of endothelial NO synthase uncoupling. Curr Pharm Des. 2014;20:3548\u201353. \nhttps:\/\/doi.org\/10.2174\/13816128113196660746\n\n.","journal-title":"Curr Pharm Des"},{"key":"699_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1006\/bbrc.1994.1909","volume":"202","author":"F Daghigh","year":"1994","unstructured":"Daghigh F, Fukuto JM, Ash DE. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem Biophys Res Commun. 1994;202:174\u201380. \nhttps:\/\/doi.org\/10.1006\/bbrc.1994.1909\n\n.","journal-title":"Biochem Biophys Res Commun"},{"key":"699_CR36","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1021\/bi002318+","volume":"40","author":"JD Cox","year":"2001","unstructured":"Cox JD, Cama E, Colleluori DM, Pethe S, Boucher JL, Mansuy D, et al. Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase. Biochemistry. 2001;40:2689\u2013701. \nhttps:\/\/doi.org\/10.1021\/bi002318+\n\n.","journal-title":"Biochemistry"},{"key":"699_CR37","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/ejn.12111","volume":"37","author":"A Quiri\u00e9","year":"2013","unstructured":"Quiri\u00e9 A, Demougeot C, Bertrand N, Mossiat C, Garnier P, Marie C, et al. Effect of stroke on arginase expression and localization in the rat brain. Eur J Neurosci. 2013;37:1193\u2013202. \nhttps:\/\/doi.org\/10.1111\/ejn.12111\n\n.","journal-title":"Eur J Neurosci"},{"key":"699_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10715762.2012.756980","volume":"47","author":"Y Akazawa","year":"2013","unstructured":"Akazawa Y, Kubo M, Zhang R, Matsumoto K, Yan F, Setiawan H, et al. Inhibition of arginase ameliorates experimental ulcerative colitis in mice. Free Radic Res. 2013;47:137\u201345. \nhttps:\/\/doi.org\/10.3109\/10715762.2012.756980\n\n.","journal-title":"Free Radic Res"},{"key":"699_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/1756-185X.13267","volume":"21","author":"H-W Tam","year":"2018","unstructured":"Tam H-W, Chen C-M, Leong P-Y, Chen CH, Li YC, Wang YH, et al. Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study. Int J Rheum Dis. 2018;21:1591\u20139. \nhttps:\/\/doi.org\/10.1111\/1756-185X.13267\n\n.","journal-title":"Int J Rheum Dis"},{"key":"699_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:480\u20139. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-206624\n\n.","journal-title":"Ann Rheum Dis"},{"key":"699_CR41","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.40565","volume":"70","author":"F Matcham","year":"2018","unstructured":"Matcham F, Galloway J, Hotopf M, Roberts E, Scott IC, Steer S, et al. The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: a systematic review and network meta-analysis. Arthritis Rheum. 2018;70:1377\u201391. \nhttps:\/\/doi.org\/10.1002\/art.40565\n\n.","journal-title":"Arthritis Rheum"},{"key":"699_CR42","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1476-5381.2011.01584.x","volume":"165","author":"S Chandra","year":"2012","unstructured":"Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW. Oxidative species increase arginase activity in endothelial cells through the RhoA\/Rho kinase pathway. Br J Pharmacol. 2012;165:506\u201319. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2011.01584.x\n\n.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"699_CR43","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/ene.13751","volume":"25","author":"H. Hashimoto","year":"2018","unstructured":"Hashimoto H, Kawamura M, Yukami T, Ishihara M, Bamba Y, Kaneshiro S, et al. Etiology of acute ischaemic cerebrovascular disease associated with rheumatoid arthritis: changes with progression of anti-inflammatory therapy. Eur J Neurol. 2018;12:1462\u20139. \nhttps:\/\/doi.org\/10.1111\/ene.13751\n\n.","journal-title":"European Journal of Neurology"},{"key":"699_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00210-018-1489-1","volume":"391","author":"W Barakat","year":"2018","unstructured":"Barakat W, Fahmy A, Askar M, El-Kannishy S. Effectiveness of arginase inhibitors against experimentally induced stroke. Naunyn Schmiedeberg's Arch Pharmacol. 2018;391:603\u201312. \nhttps:\/\/doi.org\/10.1007\/s00210-018-1489-1\n\n.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"699_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.pnpbp.2017.11.006","volume":"82","author":"M Pedard","year":"2018","unstructured":"Pedard M, Demougeot C, Prati C, Marie C. Brain-derived neurotrophic factor in adjuvant-induced arthritis in rats. Relationship with inflammation and endothelial dysfunction. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;82:249\u201354. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.006\n\n.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"699_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"B Lu","year":"2014","unstructured":"Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223\u201350. \nhttps:\/\/doi.org\/10.1007\/978-3-642-45106-5_9\n\n.","journal-title":"Handb Exp Pharmacol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-019-00699-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:19:09Z","timestamp":1584404349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-019-00699-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s12975-019-00699-7","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental procedures were approved by the local committee for ethics in animal experimentation no. 2015-001-CD-5PR of Franche-Comt\u00e9 University (Besan\u00e7on, France) and complied with the \u201cAnimal Research: Reporting In Vivo Experiments\u201d ARRIVE guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}